Cargando…
ABCB1 C3435T and CYP2C19*2 polymorphisms in a Palestinian and Turkish population: A pharmacogenetic perspective to clopidogrel
Clopidogrel is an antiplatelet drug used to prevent recurrent ischemic events after acute coronary syndrome and/or coronary stent implantation. Single nucleotide polymorphisms (SNPs) such as CYP2C19*2 and ABCB1 C3435T have been found to play a role in different individual responses to clopidogrel. S...
Autores principales: | Nassar, Suheir, Amro, Omar, Abu-Rmaileh, Hilal, Alshaer, Inji, Korachi, May, Ayesh, Suhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287958/ https://www.ncbi.nlm.nih.gov/pubmed/25606414 http://dx.doi.org/10.1016/j.mgene.2014.01.009 |
Ejemplares similares
-
ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis
por: Su, Jia, et al.
Publicado: (2012) -
Meta-Analysis of ABCB1 3435C>T Polymorphism and Colorectal Cancer
por: Zhang, Dan, et al.
Publicado: (2013) -
ABCB1 variants C3435T and T129C are not associated with colorectal cancer risk
por: Al Qahtani, Areej M, et al.
Publicado: (2019) -
The ABCB1 3435C > T polymorphism
influences docetaxel transportation in ovarian cancer
por: Yin, Beibei, et al.
Publicado: (2019) -
Increased Risk of Clopidogrel-Induced Gastric Mucosal Erosion in Elderly Chinese Men Harboring the ABCB1 3435T Allele
por: Duan, Lei, et al.
Publicado: (2020)